Need the tide to turn for biotechs generally.
Most spec money seems to be in resources atm ?
When biotechs are hot the sort of progress CDY has been making would see the share price back up to 4c I reckon.
But in the current environment - just not happening.
I think that next time you see a biotech go for a solid run on a positive announcment watch this one closely as we may have entered a positive market for bios.
Until then it seems its a good buy for contrarian traders.
cellimid didn't announce this!, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
